Immunological abnormalities in patients with haemophilia : role of factor VIII concentrate
Intermediate purity factor VIII concentrates have greatly improved care for haemophilia sufferers but have been implicated in contributing to subclinical immunodeficiency observed <i>in vivo</i>. During the course of factor VIII replacement therapy haemophilia patients are reepatedly exp...
| Main Author: | |
|---|---|
| Published: |
University of Edinburgh
1993
|
| Subjects: | |
| Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.641371 |